Cargando…

Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab

Detalles Bibliográficos
Autores principales: Romagnuolo, Maurizio, Muratori, Simona, Cattaneo, Angelo, Marzano, Angelo Valerio, Moltrasio, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540384/
https://www.ncbi.nlm.nih.gov/pubmed/35506462
http://dx.doi.org/10.1111/dth.15552
_version_ 1784803695491284992
author Romagnuolo, Maurizio
Muratori, Simona
Cattaneo, Angelo
Marzano, Angelo Valerio
Moltrasio, Chiara
author_facet Romagnuolo, Maurizio
Muratori, Simona
Cattaneo, Angelo
Marzano, Angelo Valerio
Moltrasio, Chiara
author_sort Romagnuolo, Maurizio
collection PubMed
description
format Online
Article
Text
id pubmed-9540384
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-95403842022-10-14 Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab Romagnuolo, Maurizio Muratori, Simona Cattaneo, Angelo Marzano, Angelo Valerio Moltrasio, Chiara Dermatol Ther Letters John Wiley & Sons, Inc. 2022-05-13 2022-07 /pmc/articles/PMC9540384/ /pubmed/35506462 http://dx.doi.org/10.1111/dth.15552 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters
Romagnuolo, Maurizio
Muratori, Simona
Cattaneo, Angelo
Marzano, Angelo Valerio
Moltrasio, Chiara
Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab
title Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab
title_full Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab
title_fullStr Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab
title_full_unstemmed Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab
title_short Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab
title_sort successful treatment of refractory sneddon‐wilkinson disease (subcorneal pustular dermatosis) with infliximab
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540384/
https://www.ncbi.nlm.nih.gov/pubmed/35506462
http://dx.doi.org/10.1111/dth.15552
work_keys_str_mv AT romagnuolomaurizio successfultreatmentofrefractorysneddonwilkinsondiseasesubcornealpustulardermatosiswithinfliximab
AT muratorisimona successfultreatmentofrefractorysneddonwilkinsondiseasesubcornealpustulardermatosiswithinfliximab
AT cattaneoangelo successfultreatmentofrefractorysneddonwilkinsondiseasesubcornealpustulardermatosiswithinfliximab
AT marzanoangelovalerio successfultreatmentofrefractorysneddonwilkinsondiseasesubcornealpustulardermatosiswithinfliximab
AT moltrasiochiara successfultreatmentofrefractorysneddonwilkinsondiseasesubcornealpustulardermatosiswithinfliximab